TY - JOUR
T1 - Current state of heart transplantation.
AU - McGregor, C. G.
PY - 1987/4/1
Y1 - 1987/4/1
N2 - Heart transplantation has now been accepted as a proven therapy for terminal heart disease by the medical profession and the Government, and in the USA by insurance companies. Major improvements have been achieved in donor and recipient selection and management, organ preservation, immunosuppressive techniques, and the prophylaxis, diagnosis and treatment of infectious complications. The successful introduction of cyclosporin A to clinical heart transplantation in December 1980 at Stanford University heralded a dramatic expansion in the application of heart transplantation, resulting from improved patient survival, a reduction in serious morbidity, a shorter hospital stay and reduced cost.
AB - Heart transplantation has now been accepted as a proven therapy for terminal heart disease by the medical profession and the Government, and in the USA by insurance companies. Major improvements have been achieved in donor and recipient selection and management, organ preservation, immunosuppressive techniques, and the prophylaxis, diagnosis and treatment of infectious complications. The successful introduction of cyclosporin A to clinical heart transplantation in December 1980 at Stanford University heralded a dramatic expansion in the application of heart transplantation, resulting from improved patient survival, a reduction in serious morbidity, a shorter hospital stay and reduced cost.
UR - http://www.scopus.com/inward/record.url?scp=0023322617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023322617&partnerID=8YFLogxK
M3 - Article
C2 - 3107643
AN - SCOPUS:0023322617
VL - 37
SP - 310-313, 316
JO - British journal of hospital medicine (London, England : 2005)
JF - British journal of hospital medicine (London, England : 2005)
SN - 1750-8460
IS - 4
ER -